Veeva Systems (VEEV) closed the most recent trading day at $280.68, moving +2.12% from the previous trading session.
Stock Market Today: The Dow Jones index rises Friday on U.S.-Iran peace hopes. Micron stock and Sandisk rally Friday.
VEEV's AI-powered Study Builder Agent automates clinical study setup, cutting manual work while strengthening its connected Clinical Data ecosystem.
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Veeva Systems (NYSE:VEEV) has outperformed the market over the past 10 years by 7.41% on an annualized basis producing an average annual return of 21.03%. Currently, Veeva Systems has a market capital
In recent days, Veeva Systems has rolled out new AI-powered tools such as Veeva Study Builder Agent and Veeva Falcon Router, while announcing major customer wins including Oxford Biomedica adopting Ve
Veeva Systems launches new AI study design agent Veeva Systems (VEEV) has unveiled Veeva Study Builder Agent, an AI tool that configures its EDC and Data Quality System directly from a clinical study
Jensen’s Allen Bond says investors may be overlooking Veeva, Verisk and Broadridge as AI reshapes software and business services.
View interactive chart, options flow, and AI analysis for VEEV on Zorveq Finance.
Open VEEV Chart & Analysis →